Cargando…

Open-label add-on treatment trial of minocycline in fragile X syndrome

BACKGROUND: Fragile X syndrome (FXS) is a disorder characterized by a variety of disabilities, including cognitive deficits, attention-deficit/hyperactivity disorder, autism, and other socio-emotional problems. It is hypothesized that the absence of the fragile X mental retardation protein (FMRP) le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paribello, Carlo, Tao, Leeping, Folino, Anthony, Berry-Kravis, Elizabeth, Tranfaglia, Michael, Ethell, Iryna M, Ethell, Douglas W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958860/ https://www.ncbi.nlm.nih.gov/pubmed/20937127 http://dx.doi.org/10.1186/1471-2377-10-91

Ejemplares similares

Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome
por: Lovelace, Jonathan W., et al.
Publicado: (2020)

Overactive Reproductive Axis Due to Fragile X Gene Mutation
por: Villa, Pedro, et al.
Publicado: (2021)

Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome
por: Razak, Khaleel A., et al.
Publicado: (2021)

Sensory Processing Phenotypes in Fragile X Syndrome
por: Rais, Maham, et al.
Publicado: (2018)

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
por: Berry-Kravis, E, et al.
Publicado: (2009)

FRI283 Fragile X Gene Mutations Alter GnRH Neuron And Ovarian Innervation With Consequences On Reproductive Function
por: Villa, Pedro A, et al.
Publicado: (2023)

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Hall, Deborah A., et al.
Publicado: (2020)

Targeted treatments for fragile X syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2011)

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
por: Hagerman, Randi, et al.
Publicado: (2018)

Altered GnRH neuron and ovarian innervation characterize reproductive dysfunction linked to the Fragile X messenger ribonucleoprotein (Fmr1) gene mutation
por: Villa, Pedro A., et al.
Publicado: (2023)

Minocycline and MMPs: towards treatment for Fragile X syndrome
Publicado: (2011)

An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis
por: Talvio, Karo, et al.
Publicado: (2023)

Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 Induces the Maturation of Dendritic Spines in Rat Hippocampal Neurons
por: Ethell, Iryna M., et al.
Publicado: (1999)

Matrix Metalloproteinases and Minocycline: Therapeutic Avenues for Fragile X Syndrome
por: Siller, Saul S., et al.
Publicado: (2012)

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2012)

Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome
por: Farzin, Faraz, et al.
Publicado: (2011)

Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A
por: Alusi, Ghassan, et al.
Publicado: (2022)

A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome
por: Lee, Michelle, et al.
Publicado: (2016)

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018)

Erratum to: A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome
por: Lee, Michelle, et al.
Publicado: (2017)

X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
por: Hall, Deborah A., et al.
Publicado: (2016)

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome
por: Reisinger, Debra L., et al.
Publicado: (2020)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

The challenges of clinical trials in fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2013)

A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders
por: Reinhard, Sarah M., et al.
Publicado: (2015)

Automated spatio-temporal analysis of dendritic spines and related protein dynamics
por: On, Vincent, et al.
Publicado: (2017)

Urine microRNA Profiling Displays miR-125a Dysregulation in Children with Fragile X Syndrome
por: Putkonen, Noora, et al.
Publicado: (2020)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
por: Fraint, Avram, et al.
Publicado: (2014)

Metabonomics adds a new dimension to fragile X syndrome
por: Heulens, Inge, et al.
Publicado: (2011)

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment
por: Hoffmann, Anne, et al.
Publicado: (2020)

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities
por: Weber, Jayne Dixon, et al.
Publicado: (2019)

Vocabulary comprehension in adults with fragile X syndrome (FXS)
por: Hoffmann, Anne, et al.
Publicado: (2019)

Imaging and 3D Reconstruction of Cerebrovascular Structures in Embryonic Zebrafish
por: Ethell, Douglas W., et al.
Publicado: (2014)

Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial
por: Champigny, Camille, et al.
Publicado: (2022)

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study
por: Bailey, Donald B., et al.
Publicado: (2015)

Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human Cells
por: Zhang, Jiang, et al.
Publicado: (2019)

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

Synbindin, a Novel Syndecan-2–Binding Protein in Neuronal Dendritic Spines
por: Ethell, Iryna M., et al.
Publicado: (2000)

Arbaclofen in fragile X syndrome: results of phase 3 trials
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bu0itichnsmmp2e038v6ta064s